BioSante Pharmaceuticals to Present at Upcoming Conferences
March 08 2007 - 7:00AM
Business Wire
BioSante Pharmaceuticals (AMEX: BPA) today announced that Stephen
M. Simes, president and chief executive officer, will present a
corporate overview at three upcoming conferences. The conferences
are: The Annual Sachs North American Forum for Investing and
Partnering in Biotech and Medtech on March 12, 2007 at 11:55 a.m.
EDT at the Fairmont Copley Plaza in Boston. The Arch Investment
Conference on March 21, 2007 at 1:30 p.m. EDT at the St. Regis
Hotel in New York City. The Wall Street Reporter Small-Cap
Discovery Conference on March 22, 2007 at 9:00 a.m. EDT at the
Princeton Club of New York. A live audio webcast of BioSante�s
presentation at these conferences can be accessed on the internet
by visiting www.biosantepharma.com. An archive of these
presentations will be available at the same address. About BioSante
Pharmaceuticals, Inc. BioSante is developing a pipeline of hormone
therapy products to treat both men and women. These hormone therapy
products are gel formulations for transdermal administration that
deliver bio-identical estradiol and testosterone. BioSante's lead
products include Elestrin� (estradiol gel), developed through FDA
approval by BioSante, indicated for the treatment of
moderate-to-severe vasomotor symptoms associated with menopause,
and LibiGel� (transdermal testosterone gel) in Phase III
development for the treatment of female sexual dysfunction (FSD).
The current market in the U.S. for estrogen and testosterone
products is approximately $2.5 billion. The transdermal gel
formulations used in the women's gel products are licensed by
BioSante from Antares Pharma. The company also is developing its
calcium phosphate nanotechnology (CaP) for novel vaccines,
including hepatitis B, avian flu and biodefense vaccines for toxins
such as anthrax, as well as a system for delivering drugs via
alternative routes of administration. Additional information is
available online at www.biosantepharma.com.
Biosante Pharma (AMEX:BPA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biosante Pharma (AMEX:BPA)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Biosante Pharmaceuticals (American Stock Exchange): 0 recent articles
More BioSante Pharmaceuticals, Inc. News Articles